-+ 0.00%
-+ 0.00%
-+ 0.00%
Synopsys (SNPS) Stock May Trade At A Discount Despite Fresh AI Revenue Optimism
Share
Listen to the news

Synopsys has delivered a 37.3% gain over the past five years. The real debate today is whether that share price now lines up with the cash the business is expected to generate. With fresh attention on its role in AI-focused chip design and a renewed look at electronic design automation economics, the question is how much of that story is already embedded in the stock.

  • Over 5 years, Synopsys has returned 37.3%, which puts real weight on whether the underlying cash flows are strong enough to support that journey.
  • Recent analyst commentary around AI driven revenue potential and a shift toward more consumption based EDA software can influence both the pace and visibility of future cash inflows that feed into any intrinsic value estimate.
  • If you'd rather focus on earnings, this one's for you. See why Synopsys's 83.3x P/E tells a different valuation story.

The issue now is whether Synopsys's current share price is adequately backed by the cash flows implied by a Discounted Cash Flow (DCF) view over the coming years.

If you are weighing Synopsys against other AI linked chip design stories, it can help to compare its setup with companies in 54 AI infrastructure stocks.

Does Synopsys Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at the cash Synopsys could deliver to shareholders over time and then discounts those amounts back to today. Latest twelve month free cash flow sits at about $2.7b, which gives the analysis a solid current base rather than a story that relies only on distant projections.

Looking ahead, the model assumes growing free cash flows, with analyst and estimated figures pointing to higher annual FCF by the early 2030s compared with today. That growth profile, combined with the discounting applied in the 2 Stage Free Cash Flow to Equity approach, results in an estimated intrinsic value that is meaningfully above the current share price of $467.90.

Morgan Stanley highlighting Synopsys as undervalued because the market may be underappreciating AI linked revenue potential helps explain why the DCF output still points to more cash flow support than the current price implies. Find out what Synopsys could be worth using our Discounted Cash Flow (DCF) estimate.

The Synopsys Narrative: What Would Justify Today's Price?

Narratives on Synopsys pick up where the DCF puzzle leaves off, by laying out which paths for future growth, profitability and earnings would need to hold for the shares to look meaningfully richer or cheaper than today. Rather than just a single output from a ratio or model, they spell out the set of future conditions that output rests on, so you can watch over time whether reality stays in line with that script. These sit on Simply Wall St's Community page for Synopsys and give you a structured way to compare your own expectations with what is currently implied.

One of the top community narratives on Synopsys: 20% undervalued

"The view that Synopsys is undervalued suggests the current share price does not fully reflect the company’s raised FY26 guidance..."

Discover why this Narrative puts Synopsys at 20% undervalued.

One more Synopsys question that could change the story

Cash flow models only tell part of the story for Synopsys, because the people setting priorities and the way they are rewarded can tilt long term outcomes in ways price charts never show. See who runs Synopsys and how they are paid.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending